Spots Global Cancer Trial Database for new formulation of niraparib and abiraterone acetate (aa)
Every month we try and update this database with for new formulation of niraparib and abiraterone acetate (aa) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer | NCT03748641 | Castration-Resi... | Niraparib Abiraterone Ace... Prednisone Placebo New Formulation... | 18 Years - | Janssen Research & Development, LLC | |
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer | NCT03748641 | Castration-Resi... | Niraparib Abiraterone Ace... Prednisone Placebo New Formulation... | 18 Years - | Janssen Research & Development, LLC |